Akerna Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Significant Transactions (Details Textual)

Significant Transactions (Details Textual)		1 Months Ended				3 Months Ended	12 Months Ended
Significant Transactions (Details Textual)	Apr. 01, 2021 USD ($) shares	Jan. 31, 2023 USD ($)	May 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	May 31, 2021 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) shares	Jun. 30, 2022	Oct. 01, 2021 USD ($) shares	Dec. 31, 2020 USD ($)
Business Acquisition [Line Items]
Transaction costs					$ 600,000
Restructuring and Related Cost, Number of Positions Eliminated, Period Percent			33.00%
Common stock, shares issued \| shares							4,602,780	1,550,094
Revenues							$ 13,645,030	$ 17,627,097
Exchangeable shares \| shares							3,294,574		23,614
General and administrative expenses					$ 100,000
Number of employees					59
Capitalized software, net							$ 654,556	6,940,653
Goodwill							1,708,303	32,844,297				$ 41,789,527
Impairments of long-lived assets							22,800,000
Marketing Expense			$ 300,000
Development Costs, Period Cost			$ 200,000
Reduction of purchase price										25.00%
Impairments of long-lived assets							61,778,605	14,383,310
Revenues								28.8
Net loss								(31.4)
Viridian Sciences Inc. [Member]
Business Acquisition [Line Items]
Exchange shares value	$ 6,200,000
Impairments of long-lived assets								0
Cannabis [Member]
Business Acquisition [Line Items]
Revenues							8,800,000	2,400,000
Contingent consideration								6,300,000
Common stock issued in business combinations				$ 12,000,000
Cash											$ 5,000,000
Aggregate stock price											$ 8,000,000
Viridian [Member]
Business Acquisition [Line Items]
Revenues							1,700,000	2,400,000
Capitalized software, net							600,000
Impairment of Intangible Assets (Excluding Goodwill)							1,000,000
Goodwill							5,400,000
Impairments of long-lived assets							7,000,000
365 Cannabis [Member]
Business Acquisition [Line Items]
Common stock, shares issued \| shares											178,572
Contingent consideration									$ 3,300,000
Cash											$ 527,000
Impairment of Intangible Assets (Excluding Goodwill)							9,700,000
Goodwill							12,500,000
Impairments of long-lived assets							22,200,000
Initially measured at a fair value											$ 6,300,000
ReductionOfWorkingCapital						$ 1,500,000	200,000
Receivables, Net, Current							$ 400,000
Shares held in escrow, shares \| shares							13,988
Shares held in escrow, value							$ 900,000
Impairments of long-lived assets								$ 0
Percentage of amount reduced if Earn-out Obligation paid in cash									25.00%
Viridian Sciences [Member]
Business Acquisition [Line Items]
Exchangeable shares \| shares	51,550
Subsequent Event [Member] \| 365 Cannabis [Member]
Business Acquisition [Line Items]
Revenues		$ 2,300,000
Cash		$ 500,000